Aqr Capital Management LLC Vir Biotechnology, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 16,922 shares of VIR stock, worth $125,222. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,922

Previous 15,037 12.54%

Holding current value

$125,222

Previous $133,000 5.26%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.26 - $10.7 $13,685 - $20,169	1,885 Added 12.54%	16,922 $126,000
Q2 2024 Aug 14, 2024	SELL	$7.63 - $12.66 $84,097 - $139,538	-11,022 Reduced 42.3%	15,037 $133,000
Q1 2024 May 15, 2024	BUY	$8.6 - $11.9 $47,867 - $66,235	5,566 Added 27.16%	26,059 $263,000
Q4 2023 Feb 14, 2024	SELL	$7.76 - $10.29 $538,404 - $713,940	-69,382 Reduced 77.2%	20,493 $206,000
Q3 2023 Nov 14, 2023	SELL	$9.14 - $24.62 $1.83 Million - $4.94 Million	-200,481 Reduced 69.05%	89,875 $842,000
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $1.1 Million - $1.29 Million	-47,316 Reduced 14.01%	290,356 $7.12 Million
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $645,517 - $894,619	28,999 Added 9.39%	337,672 $7.86 Million
Q4 2022 Feb 14, 2023	SELL	$19.96 - $28.22 $879,437 - $1.24 Million	-44,060 Reduced 12.49%	308,673 $7.81 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $2.61 Million - $4.45 Million	143,024 Added 68.2%	352,733 $6.8 Million
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $1.91 Million - $2.67 Million	100,139 Added 91.39%	209,709 $5.34 Million
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $2.32 Million - $4.38 Million	109,570 New	109,570 $2.82 Million
Q4 2021 Feb 14, 2022	SELL	$30.97 - $54.03 $294,153 - $513,176	-9,498 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $331,480 - $518,020	9,498 New	9,498 $413,000
Q2 2021 Aug 16, 2021	SELL	$38.75 - $51.0 $469,301 - $617,661	-12,111 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$26.34 - $83.07 $319,003 - $1.01 Million	12,111 New	12,111 $621,000
Q4 2020 Feb 16, 2021	SELL	$25.51 - $43.38 $549,561 - $934,535	-21,543 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$28.28 - $53.6 $609,236 - $1.15 Million	21,543 New	21,543 $740,000

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Vir Biotechnology, Inc. Transaction History